Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal imm...
Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
About this item
Full title
Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Vaccine, 2020-09, Vol.38 (39), p.6141-6152
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlight•IIV formulated with ssRNA adjuvant induced humoral and cellular immune responses. •IIV formulated with ssRNA adjuvant induced IgA. •IIV formulated with ssRNA adjuvant protects against heterologous viral infection.
Alternative Titles
Full title
Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2430099315
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2430099315
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2020.07.022
